Condition: Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Sponsor: AbbVie
This is a Phase 2, open-label, multicenter study, evaluating the efficacy of venetoclax in participants with relapsed or refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) either in presence of 17p deletion (Cohort 1) or those who have failed a B-receptor signaling pathway inhibitor (BCRI) therapy and who have also failed, or were unable to receive chemoimmunotherapy (CIT) irrespective of 17p status (Cohort 2).
This description comes directly from the study's public registry record.
ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com
Always discuss trial participation with your own doctor first.
| Concord Repatriation General Hospital /ID# 201261 | Concord, New South Wales, Australia | Recruiting |
| St George Hospital /ID# 206484 | Kogarah, New South Wales, Australia | Recruiting |
| Monash Health - Monash Medical Centre /ID# 201263 | Clayton, Victoria, Australia | Completed |
| Anhui Provincial Cancer Hospital /ID# 209458 | Hefei, Anhui, China | Recruiting |
| Peking University People's Hospital /ID# 156575 | Beijing, Beijing Municipality, China | Recruiting |
| Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 156576 | Beijing, Beijing Municipality, China | Recruiting |
| Fujian Medical University Union Hospital /ID# 156579 | Fuzhou, Fujian, China | Recruiting |
| Guangdong Provincial Peoples Hospital /ID# 160509 | Guangzhou, Guangdong, China | Recruiting |
| Nanfang Hospital of Southern Medical University /ID# 156571 | Guangzhou, Guangdong, China | Recruiting |
| The Second Hospital of Hebei Medical University /ID# 159143 | Shijiazhuang, Hebei, China | Completed |
| Henan Cancer Hospital /ID# 156573 | Zhengzhou, Henan, China | Recruiting |
| Tongji Hospital Tongji Medical College of HUST /ID# 156589 | Wuhan, Hubei, China | Recruiting |
+ 19 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02966756